Trials / Sponsors / Kari Wisinski
Kari Wisinski
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers TNBC - Triple-Negative Breast Cancer | Phase 1 / Phase 2 | 2019-04-17 |
| Active Not Recruiting | Ribociclib and Bicalutamide in AR+ TNBC Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2018-05-07 |